Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Enrollment of pediatric and adolescent patients with MAGE-A4+advanced synovial sarcoma into cohort 2 of SPEARHEAD-1: a phase 2 trial of afamitresgene autoleucel ("afami-cel" [formerly ADP-A2M4])
Enrollment of pediatric and adolescent patients with MAGE-A4+advanced synovial sarcoma into cohort 2 of SPEARHEAD-1: a phase 2 trial of afamitresgene autoleucel ("afami-cel" [formerly ADP-A2M4]) Lunt, C., D'Angelo, S. P., Razak, A., Wagner, M. J., Van Tine, B. A., Ganjoo, K., Blay, J., Araujo, D. M., Agulnik, M., Glod, J. W., Van Winkle, E., Elefant, E., Biswas, S., Williams, D., Le Cesne, A. AMER ASSOC CANCER RESEARCH. 2022: 3-4View details for Web of Science ID 000860580000005